Brief: Neuronetics Announces Clinical Presence At The 2025 Clinical TMS Society Annual Meeting And Progress In Greenbrook's Personalized Care Trial Program
10/06/2025 15:10
June 10 (Reuters) - Neuronetics Inc STIM.O: NEURONETICS ANNOUNCES CLINICAL PRESENCE AT THE 2025 CLINICAL TMS SOCIETY ANNUAL MEETING AND PROGRESS IN GREENBROOK’S PERSONALIZED CARE TRIAL PROGRAM Source text: ID:nGNX6RWHFz Further company coverage: STIM.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neuronetics
See all newsBrief: Neuronetics And Ant Neuro Announce Strategic Collaboration To Integrate Neuronavigation With Neurostar Tms Treatment
Neuronetics Q1 revenue rises 8%, slightly beats estimates
Brief: Neuronetics Inc - Board Reviews Jorey Chernett Letter And Acknowledges Shareholder Engagement
Brief: Neuronetics Inc Initiates Workforce Reduction Impacting Up To 5% Of Employees
Brief: Neuronetics Announces Chief Financial Officer Transition